Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Non-Disseminated Breast Cancer : Controversial Issues in Management, Paperback / softback Book

Non-Disseminated Breast Cancer : Controversial Issues in Management Paperback / softback

Edited by Gilbert H. Fletcher, Seymour H. Levitt

Part of the Radiation Oncology series

Paperback / softback

Description

In the last two decades, there has been a major increase in the actual numbers of women diagnosed with breast cancer (from 65000 new cases 20 years ago in the United States to 183000 in 1993).

Concomitant with this has been a shift toward making the diagnosis earlier and toward diagnosing an earlier stage ofthe disease (more than 70% of diagnoses were of advanced-stage disease two decades ago, whereas more than 70% of diagnoses are now earlier-stage disease in 1992).

These changes are clearly related to the woman's greater sensitivity to abnormalities in the breast and her seeking medical care, to the physician's greater awareness of the potential diagnosis of cancer, and to the major and important impact of mammographic screening.

These changes have had a major impact on the questions of appropriate treatment, thereby contributing to the controversies in the disease.

What is the role of surgery? What are the respective advantages of radical mastectomy, modified radical mastectomy, and conservation surgery with and without supplementary treatment?

What is the role of radiation therapy? When should radiation therapy be performed after mastectomy, and what volumes should be irradiated post mastectomy?

Where is radiation therapy indicated after conservation surgery, and when is radiation therapy an effective palliative treatment measure?

When should chemotherapy and/or hormonal therapy be used as an adjuvant to primary treatment and when as an effective palliative treatment?

This book by Levitt and Fletcher addresses these critical and important issues.

Information

  • Format:Paperback / softback
  • Pages:168 pages, 32 Tables, black and white; 5 Illustrations, black and white; XIV, 168 p. 5 illus.
  • Publisher:Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • Publication Date:
  • Category:
  • ISBN:9783642845956
Save 18%

£99.99

£81.69

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

  • Format:Paperback / softback
  • Pages:168 pages, 32 Tables, black and white; 5 Illustrations, black and white; XIV, 168 p. 5 illus.
  • Publisher:Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • Publication Date:
  • Category:
  • ISBN:9783642845956

Also in the Radiation Oncology series  |  View all